BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Baar ACG, Meiring S, Holleman F, Hopkins D, Mingrone G, Devière J, Nieuwdorp M, Bergman JJGHM. Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling? Gut 2021;70:2196-204. [PMID: 34497147 DOI: 10.1136/gutjnl-2020-323931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee D, Kim J, Choi S, Choi J, Woo Lee J, Sung Kang K, Hee Shim S. 2,3-Dihydrosorbicillin and chrysopanol stimulate insulin secretion in INS-1 cells. Bioorg Med Chem Lett 2023;83:129186. [PMID: 36781148 DOI: 10.1016/j.bmcl.2023.129186] [Reference Citation Analysis]
2 Meiring S, Busch CBE, van Baar ACG, Hemke R, Holleman F, Nieuwdorp M, Bergman JJGHM. Eliminating exogenous insulin therapy in patients with type 2 diabetes by duodenal ablation and GLP-1RA decreases risk scores for cardiovascular events. Cardiovasc Diabetol 2022;21:191. [PMID: 36138441 DOI: 10.1186/s12933-022-01628-z] [Reference Citation Analysis]
3 Yu C, Chen J, Ren J. Advances of microRNAs in regulating mitochondrial function: new potential application in NAFLD treatment. Mol Biol Rep 2022. [PMID: 35612781 DOI: 10.1007/s11033-022-07503-0] [Reference Citation Analysis]